Enhancement of insulin-mediated rat muscle glucose uptake and microvascular perfusion by 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside

被引：0
|
作者：
Eloise A Bradley
Lei Zhang
Amanda J Genders
Stephen M Richards
Stephen Rattigan
Michelle A Keske
机构：
[1] University of Tasmania,Menzies Institute for Medical Research
[2] Garvan Institute of Medical Research,Institute of Sport, Exercise and Active Living (ISEAL)
[3] Victoria University,School of Medicine
[4] University of Tasmania,undefined
来源：
Cardiovascular Diabetology | / 14卷
关键词：
Muscle; Insulin; Glucose; Microcirculation; Microbubbles;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Loss of the Anorexic Response to Systemic 5-Aminoimidazole-4-Carboxamide-1-β-D-Ribofuranoside Administration Despite Reducing Hypothalamic AMP-Activated Protein Kinase Phosphorylation in Insulin-Deficient Rats
    Vitzel, Kaio F.
    Bikopoulos, George
    Hung, Steven
    Curi, Rui
    Ceddia, Rolando B.
    PLOS ONE, 2013, 8 (08):
  • [32] Knockout of the α2 but not α1 5′-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranoside- but not contraction-induced glucose uptake in skeletal muscle
    Jorgensen, SB
    Viollet, B
    Andreelli, F
    Frosig, C
    Birk, JB
    Schjerling, P
    Vaulont, S
    Richter, EA
    Wojtaszewski, JFP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (02) : 1070 - 1079
  • [33] 5-Aminoimidazole-4-carboxamide-1β-D-ribofuranoside alleviated carbon tetrachloride-induced acute hepatitis in mice
    Yang, Changming
    Gong, Xianqiong
    Ai, Qing
    Ge, Pu
    Lin, Ling
    Zhang, Li
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 25 (02) : 393 - 399
  • [34] Stimulation of rat muscle glucose uptake by 5-aminoimidazole-4-carboxamide riboside.
    Bergeron, R
    Russell, RR
    Young, LH
    Ren, JM
    Lee, A
    Shulman, GI
    DIABETOLOGIA, 1998, 41 : A263 - A263
  • [35] 5-Aminoimidazole-4-carboxamide-1-β-4-ribofuranoside (AICAR) enhances the efficacy of rapamycin in human cancer cells
    Mukhopadhyay, Suman
    Chatterjee, Amrita
    Kogan, Diane
    Patel, Deven
    Foster, David A.
    CELL CYCLE, 2015, 14 (20) : 3331 - 3339
  • [36] Anti-cancer Effects of 5-Aminoimidazole-4-Carboxamide-1-β-D-Ribofuranoside (AICAR) on Triple-negative Breast Cancer (TNBC) Cells: Mitochondrial Modulation as an Underlying Mechanism
    Tripathi, Versha
    Jaiswal, Pooja
    Assaiya, Anshul
    Kumar, Janesh
    Parmar, Hamendra Singh
    CURRENT CANCER DRUG TARGETS, 2022, 22 (03) : 245 - 256
  • [37] Prevention of ischemic vascular injury: targeting cellular stress in the endothelium with 5-aminoimidazole-4-carboxamide 1-β-D-ribofuranoside
    Johnson, Sarah
    Banek, Christopher
    Gillham, Haley
    Needham, Karen
    Gilbert, Jeffrey
    FASEB JOURNAL, 2014, 28 (01):
  • [38] 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes
    Gaidhu, Mandeep Pinky
    Fediuc, Sergiu
    Ceddia, Rolando Bacis
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (36) : 25956 - 25964
  • [39] 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) alters in vitro vasomotor responses of thoracic aorta rings from spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats
    Ford, Rebecca J.
    Rush, James W. E.
    FASEB JOURNAL, 2007, 21 (06): : A1230 - A1230
  • [40] Cell cycle regulation via p53 phosphorylation by a 5′-AMP activated protein kinase activator, 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside, in a human hepatocellular carcinoma cell line
    Imamura, K
    Ogura, T
    Kishimoto, A
    Kaminishi, M
    Esumi, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 287 (02) : 562 - 567
12345